gms | German Medical Science

14th Triennial Congress of the International Federation of Societies for Surgery of the Hand (IFSSH), 11th Triennial Congress of the International Federation of Societies for Hand Therapy (IFSHT)

17.06. - 21.06.2019, Berlin

Article

Send article

Costs of productivity loss after surgery for first carpometacarpal osteoarthritis (CMC-1 OA)

Meeting Abstract

Search Medline for

  • presenting/speaker Mark Van Der Oest - ErasmusMC, Rotterdam, Netherlands
  • Joris Teunissen - ErasmusMC, Rotterdam, Netherlands
  • Ralph Poelstra - ErasmusMC, Rotterdam, Netherlands
  • Reinier Feitz - Xpert Clinic, Eindhoven, Netherlands
  • Harm Slijper - Xpert Clinic, Eindhoven, Netherlands
  • Jarry Porsius - ErasmusMC, Rotterdam, Netherlands
  • Alex Burdorf - ErasmusMC, Rotterdam, Netherlands
  • Ruud Selles - ErasmusMC, Rotterdam, Netherlands

International Federation of Societies for Surgery of the Hand. International Federation of Societies for Hand Therapy. 14th Triennial Congress of the International Federation of Societies for Surgery of the Hand (IFSSH), 11th Triennial Congress of the International Federation of Societies for Hand Therapy (IFSHT), 11th Triennial Congress of the International Federation of Societies for Hand Therapy (IFSHT). Berlin, 17.-21.06.2019. Düsseldorf: German Medical Science GMS Publishing House; 2020. DocIFSSH19-1566

doi: 10.3205/19ifssh0866, urn:nbn:de:0183-19ifssh08664

Published: February 6, 2020

© 2020 Van Der Oest et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.

Outline

Text

Objectives/Interrogation: Recent studies on first carpometacarpal osteoarthritis (CMC-1 OA) have focused on establishing the optimal treatment and determining prognostic factors for this treatment. However, little is know about the cost that are associated with productivity loss after surgery. This study aim to determine the duration until patients returned to work and the associated costs in patients with CMC-1 OA.

Methods: We included all patients that were surgically treated for CMC-1 OA and had a paid job at the time of surgery. Return to work was measured by questionnaire that was administered as part of routine care. All patients that did not provide information on return to work were excluded. Cox analysis was used to calculate the time until patients returned to work. The human capital method was used to calculated the costs of productivity loss.

Results and Conclusions: 629 patients were included in the final analysis, their mean (±SD) age was 55 (±6). One year after surgery 79% of all patients had returned to performing their original work. The median time to return to work was 12 weeks (Q1 - Q3, 6 - 22). Median costs of productivity loss were 11.448 euro (Q1 - Q3, 5.724 euro - 21.000 euro). Performing physically heavy work was associated with a later return to work and thus with higher costs of productivity loss.

Surgical treatment of CMC-1 OA results in a long period of absenteeism and thus high indirect costs of the treatment. Additional interventions in the follow-up of the surgery designed to expedite the return to work may therefore be considered to reduce the indirect costs of surgery.